Advances in the Diagnosis and Therapy of Double-hit Lymphoma--Review / 中国实验血液学杂志
Journal of Experimental Hematology
; (6): 1311-1315, 2019.
Article
em Zh
| WPRIM
| ID: wpr-775723
Biblioteca responsável:
WPRO
ABSTRACT
Abstract Double-hit lymphoma (DHL) is a high-grade B-cell lymphoma with MYC and BCL-2/BCL-6 rearrangement, which is a invasive disease with a poor prognosis. FISH is the most important diagnostic method. There is no standard protocol for this disease yet. New therapeutic approaches including targeted therapy,checkpoint inhibitors and chimeric antigen receptor T-cell therapy are changing the paradigm of treatment for DHL. This review summarizes new developments in diagnosis and treatment of double-hit lymphoma.
Texto completo:
1
Base de dados:
WPRIM
Assunto principal:
Imunoterapia Adotiva
/
Linfoma de Células B
/
Proteínas Proto-Oncogênicas c-myc
/
Proteínas Proto-Oncogênicas c-bcl-2
/
Predisposição Genética para Doença
/
Proteínas Proto-Oncogênicas c-bcl-6
Tipo de estudo:
Diagnostic_studies
/
Guideline
Limite:
Humans
Idioma:
Zh
Ano de publicação:
2019
Tipo de documento:
Article